A clinical and biochemical assessment of methotrexate in rheumatoid arthritis
β Scribed by T. J. Tait; P. Gallez; C. Astbury; H. A. Bird
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 446 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Etretinate (Tigason; Roche), which is effective in the treatment of psoriatic arthritis has immunomodulating activity in vivo. We have therefore assessed this drug in an open clinical and biochemical assessment of 24 weeks duration in rheumatoid arthritis. The treatment dose was 1.0 mg/kg/day for th
To measure the effect of methotrexate (MTX) treatment in rheumatoid arthritis (RA) on the expression of synovial collagenase, stromelysin, and tissue inhibitor of metalloproteinase 1 (TIMP-1) gene expression in a prospective study. Methods. Serial percutaneous synovial biopsies (pretreatment and af